Viking Therapeutics, Inc. (VKTX) Social Stream
Viking Therapeutics Inc (VKTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VKTX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
VKTX's average price target has moved down $1.84 over the prior 45 weeks.
Over the past 44 weeks, VKTX's average upside potential has been 244.54%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VKTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 weeks, VKTX's average broker recommendation rating improved by 0.56.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Viking Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 384.15% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, Viking Therapeutics Inc's variance in analysts' estimates is lower than -261.79% of them.
- Viking Therapeutics Inc's number of analysts covering the stock is greater than 383.47% of stocks in the small market cap category.
- Viking Therapeutics Inc's average analyst price target is higher than 120.93% of Healthcare stocks.
In the Pharmaceutical Products industry, VINC, VERU, and VERA are the three stocks most similar to Viking Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding VKTX using the data that counts. Try POWR Ratings for free.